Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Colonoscopy and sigmoidoscopy provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against cancer of the proximal colon, remain uncertain. METHODS: We examined the association of the use of lower endoscopy (updated biennially from 1988 through 2008) with colorectal-cancer incidence (through June 2010) and colorectal-cancer mortality (through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow-up Study. RESULTS: Among 88,902 participants followed over a period of 22 years, we documented 1815 incident colorectal cancers and 474 deaths from colorectal cancer. With endoscopy as compared with no endoscopy, multivariate hazard ratios for colorectal cancer were 0.57 (95% confidence interval [CI], 0.45 to 0.72) after polypectomy, 0.60 (95% CI, 0.53 to 0.68) after negative sigmoidoscopy, and 0.44 (95% CI, 0.38 to 0.52) after negative colonoscopy. Negative colonoscopy was associated with a reduced incidence of proximal colon cancer (multivariate hazard ratio, 0.73; 95% CI, 0.57 to 0.92). Multivariate hazard ratios for death from colorectal cancer were 0.59 (95% CI, 0.45 to 0.76) after screening sigmoidoscopy and 0.32 (95% CI, 0.24 to 0.45) after screening colonoscopy. Reduced mortality from proximal colon cancer was observed after screening colonoscopy (multivariate hazard ratio, 0.47; 95% CI, 0.29 to 0.76) but not after sigmoidoscopy. As compared with colorectal cancers diagnosed in patients more than 5 years after colonoscopy or without any prior endoscopy, those diagnosed in patients within 5 years after colonoscopy were more likely to be characterized by the CpG island methylator phenotype (CIMP) (multivariate odds ratio, 2.19; 95% CI, 1.14 to 4.21) and microsatellite instability (multivariate odds ratio, 2.10; 95% CI, 1.10 to 4.02). CONCLUSIONS: Colonoscopy and sigmoidoscopy were associated with a reduced incidence of cancer of the distal colorectum; colonoscopy was also associated with a modest reduction in the incidence of proximal colon cancer. Screening colonoscopy and sigmoidoscopy were associated with reduced colorectal-cancer mortality; only colonoscopy was associated with reduced mortality from proximal colon cancer. Colorectal cancer diagnosed within 5 years after colonoscopy was more likely than cancer diagnosed after that period or without prior endoscopy to have CIMP and microsatellite instability. (Funded by the National Institutes of Health and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prospective cohort study involving 89000 healthcare workers over 24 years concluded that systematic use of colonoscopy for screening results in a 68% reduction in CRC mortality compared to individuals without CRC screening[66].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [66]
In the citing paper
“Every 1% rise in ADR will lead to a 3% reduction in the risk of interval colorectal cancer [9].”
From Advancing Colorectal Cancer Screening: A Comprehensive Systematic Review of Artificial Intelligence (AI)-Assisted Versus Routine Colonoscopy (2023) · cites this paper as [9]
Citations
Cites
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O'Brien, M. J., Lansdorp-Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Quality Indicators for Colonoscopy and the Risk of Interval Cancer
Kaminski, M. F., Regula, J., Kraszewska, E., Polkowski, M., Wojciechowska, U., Didkowska, J., Zwierko, M., Rupinski, M., Nowacki, M. P., & Butruk, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907667 · Cited by 2,010
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959
Lieberman, D. A., Rex, D. K., Winawer, S. J., Giardiello, F. M., Johnson, D. A., & Levin, T. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.001 · Cited by 1,892
Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., et al. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0018 · Cited by 1,801
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008
Rex, D. K., Johnson, D. A., Anderson, J. C., Schoenfeld, P. S., Burke, C. A., & Inadomi, J. M. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.104 · Cited by 1,401
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps
Maisonneuve, P., Botteri, E., & Lowenfels, A. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.039 · Cited by 1,183
Cited by
Items 201–300 of 1,000
Yang, T.-W., Lee, W.-H., Tu, S.-J., Huang, W.-C., Chen, H., Sun, T.-H., Tsai, M.-C., Wang, C., Chen, H., Huang, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45588-z · Cited by 86
Effectiveness, training and quality assurance of colonoscopy screening for colorectal cancer
Robertson, D. J., Kaminski, M. F., & Bretthauer, M. (2015) · Gut · doi:10.1136/gutjnl-2014-308076 · Cited by 73
on behalf of the COLONPREDICT study investigators, Cubiella, J., Vega, P., Salve, M., Díaz-Ondina, M., Alves, M. T., Quintero, E., Álvarez-Sánchez, V., Fernández‐Bañares, F., Boadas, J., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0668-5 · Cited by 73
“Moreover, we have confirmed the protective effect of previous colonoscopy and treatment with aspirin in symptomatic patients [29, 30].”
BackgroundLin, O. S. T., Kozarek, R. A., & Cha, J. M. (2014) · Intestinal Research · doi:10.5217/ir.2014.12.4.268 · Cited by 72
“Retrospective case-control studies provided the initial data.3,7-9,23 Five studies from various countries, previously described, included patients who had been exposed to either sigmoidoscopy or colonoscopy, but if we stratify the data it is clear that colonoscopy is associated with decreased incidence of CRC, with an…”
BackgroundResultInfluentialKumar, S., Thosani, N. C., Ladabaum, U., Friedland, S., Chen, A. M., Kochar, R., & Banerjee, S. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.11.030 · Cited by 71
A Randomized Controlled Trial of Opt-in Versus Opt-Out Colorectal Cancer Screening Outreach
Mehta, S. J., Khan, T. M., Guerra, C. E., Reitz, C., McAuliffe, T. L., Volpp, K. G. M., Asch, D. A., & Doubeni, C. A. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0151-3 · Cited by 76
Yoshida, N., Dohi, O., Inoue, K., Yasuda, R., Murakami, T., Hirose, R., Inoue, K., Naito, Y., Inada, Y., Ogiso, K., et al. (2018) · Gut and Liver · doi:10.5009/gnl18276 · Cited by 70
Liu, M., He, Z., Guo, C., Xu, R., Li, F., Ning, T., Pan, Y., Li, Y., Ding, H., Li, Z., et al. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy291 · Cited by 69
Lieberman, D. A., Sullivan, B. A., Hauser, E. R., Qin, X., Musselwhite, L. W., O’Leary, M. C., Redding, T. S., Madison, A. N., Bullard, A. J., Thomas, R., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.052 · Cited by 68
State of the Science on Quality Indicators for Colonoscopy and How to Achieve Them
May, F. P., & Shaukat, A. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000622 · Cited by 70
“Currently, the large majority of colorectal cancer (CRC) screening in the United States is performed with colonoscopy (2), which is estimated to reduce CRC incidence and mortality by 40% and 50%, respectively (3,4).”
BackgroundUgai, T., Haruki, K., Harrison, T. A., Cao, Y., Qu, C., Chan, A. T., Campbell, P. T., Akimoto, N., Berndt, S. I., Brenner, H., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002171 · Cited by 84
Self-citationKahi, C. J., Pohl, H., Myers, L. J., Mobarek, D., Robertson, D. J., & Imperiale, T. F. (2018) · Annals of Internal Medicine · doi:10.7326/m17-0723 · Cited by 68
Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program
Bronzwaer, M. E. S., Depla, A. C. T. M., van Lelyveld, N., Spanier, B. W. M., Oosterhout, Y. H., van Leerdam, M. E., Spaander, M. C. W., Dekker, E., van Haastert, M., Keller, J. J., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.09.011 · Cited by 76
Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer
Kim, K., Castro, E. J., Shim, H., Advincula, J. V. G., & Kim, Y. W. (2018) · Annals of Coloproctology · doi:10.3393/ac.2018.12.17 · Cited by 74
“The CIMP definition criteria vary among studies, with some using at least three loci methylated from 5 to 15 marker panels and different cutoff values to group them as either CIMP-positive (which is further grouped as CIMP-high and CIMP-low) or CIMP-negative [8, 16].”
BackgroundInfluentialBishay, K., Causada-Calo, N. S., Scaffidi, M. A., Walsh, C. M., Anderson, J., Rostom, A., Dube, C., Keswani, R. N., Heitman, S. J., Hilsden, R. J., et al. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.03.3865 · Cited by 68
Keswani, R. N., Yadlapati, R. H., Gleason, K. M., Ciolino, J. D., Manka, M., O’Leary, K. J., Barnard, C., & Pandolfino, J. E. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.103 · Cited by 67
Detection of Sessile Serrated Adenomas in the Proximal Colon Using Wide-Field Fluorescence Endoscopy
Joshi, B. P., Dai, Z., Gao, Z., Lee, J. H., Ghimire, N., Chen, J., Prabhu, A., Wamsteker, E. J., Kwon, R. S., Elta, G. H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.12.009 · Cited by 68
Lew, J., John, D. J. B. S., Macrae, F., Emery, J. D., Ee, H. C., Jenkins, M. A., He, E., Grogan, P. B., Caruana, M., Sarfati, D., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31314 · Cited by 66
“Trials and observational studies have shown that colorectal cancer mortality can be reduced by screening with guaiac Faecal Occult Blood Testing (gFOBT) (by 13–33%), flexible sigmoidoscopy (FS) (by 21–31%) and colonoscopy (by 68–88%).(5,9,10) Potential alternative screening technologies, such as computed tomographic c…”
BackgroundBhattacharyya, R., Chedgy, F., Kandiah, K., Fogg, C., Higgins, B., Haysom-Newport, B., Gadeke, L., Thursby‐Pelham, F., Ellis, R. D., Goggin, P. M., et al. (2017) · Endoscopy · doi:10.1055/s-0043-111718 · Cited by 65
Stool Testing for Colorectal Cancer Screening
Robertson, D. J., & Imperiale, T. F. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.045 · Cited by 66
Song, M., Emilsson, L., Roelstraete, B., & Ludvigsson, J. F. (2021) · BMJ · doi:10.1136/bmj.n877 · Cited by 74
Multi-Target Stool DNA Test: A New High Bar for Noninvasive Screening
Ahlquist, D. A. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3451-5 · Cited by 73
“As currently practiced, screening colonoscopy has a much lower benefit on incidence and mortality reduction from right-sided than left-sided CRC [24, 26, 50], interval cancers are disproportionately right-sided [9, 51], quality metrics of this operator-dependent procedure vary widely for both adenoma and sessile serra…”
Stoffel, E. M., Erichsen, R., Frøslev, T., Pedersen, L. H., Vyberg, M., Koeppe, E. S., Crockett, S. D., Hamilton, S. R., Sørensen, H. T., & Baron, J. A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.010 · Cited by 66
Current status of surgical treatment of rectal cancer in China
Yang, Y., Wang, H.-Y., Chen, Y., Chen, J., Song, C., & Gu, J. F. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001076 · Cited by 69
Key quality indicators in colonoscopy
Rex, D. K. (2022) · Gastroenterology report · doi:10.1093/gastro/goad009 · Cited by 74
Management of colorectal T1 carcinoma treated by endoscopic resection
Saitoh, Y., Inaba, Y., Sasaki, T., Sugiyama, R., Sukegawa, R., & Fujiya, M. (2015) · Digestive Endoscopy · doi:10.1111/den.12503 · Cited by 70
Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions
Lochhead, P. J., Chan, A. T., Giovannucci, E. L., Fuchs, C. S., Wu, K., Nishihara, R., O’Brien, M. J., & Ogino, S. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.153 · Cited by 70
Self-citationElmunzer, B. J., Singal, A. G., Sussman, J. B., Deshpande, A. R., Sussman, D. A., Conte, M. L., Dwamena, B. A., Rogers, M. A. M., Schoenfeld, P., Inadomi, J. M., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.10.033 · Cited by 63
Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study
Kubisch, C. H., Crispin, A., Mansmann, U., Göke, B., & Kolligs, F. T. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.04.008 · Cited by 72
Comparative effectiveness of screening strategies for colorectal cancer
Barzi, A., Lenz, H., Quinn, D. I., & Sadeghi, S. (2017) · Cancer · doi:10.1002/cncr.30518 · Cited by 68
“The incidence of CRC in the nonscreened population was modeled using SEER incidence data from 1990 through 1995 (before the full impact of screening incidence reduction was reflected in the SEER data), and the incidence reduction attributable to screening was modeled using long-term lower endoscopy data.(6,31) Individ…”
MethodDual roles of yes-associated protein (YAP) in colorectal cancer
Ou, C., Sun, Z., Li, S., Li, G., Li, X., & Ma, J. (2017) · Oncotarget · doi:10.18632/oncotarget.20155 · Cited by 66
Endoscopist factors that influence serrated polyp detection: a multicenter study
Crockett, S. D., Gourevitch, R. A., Morris, M. M., Carrell, D., Rose, S., Shi, Z., Greer, J. B., Schoen, R. E., & Mehrotra, A. (2018) · Endoscopy · doi:10.1055/a-0597-1740 · Cited by 62
Lee, Y., Chen, S. L., Yen, A. M., Chiu, S. Y., Fann, J. C., Chuang, S.-L., Chiang, T., Chou, C., Chiu, H., Wu, M., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw269 · Cited by 64
“CRCs (8).”
InfluentialMatsuda, T., Fujii, T., Sano, Y., Kudo, S., Oda, Y., Hotta, K., Shimoda, T., Saito, Y., Kobayashi, N., Sekiguchi, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321996 · Cited by 60
Tsoi, K. K. F., Hirai, H. W., Chan, F. C. H., Griffiths, S. M., & Sung, J. J. �. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.09.155 · Cited by 65
Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer
Fujiyoshi, K., Väyrynen, J. P., Borowsky, J., Papke, D. J., Arima, K., Haruki, K., Kishikawa, J., Akimoto, N., Ugai, T., Lau, M. C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102860 · Cited by 69
Self-citationThe effect of quality of segmental bowel preparation on adenoma detection rate
Guo, R., Wang, Y., Liu, M., Ge, J., Zhang, L., Ma, L., Huang, W., & Zhai, H. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1019-8 · Cited by 59
Clinical and Genetic Factors to Inform Reducing Colorectal Cancer Disparitites in African Americans
Carethers, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00531 · Cited by 64
Wong, J. C. T., Chiu, H., Kim, H., Byeon, J., Matsuda, T., Kobayashi, N., Wu, D., Ong, D. E., & Sung, J. J. �. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.11.014 · Cited by 59
Application of artificial intelligence to the diagnosis and therapy of colorectal cancer.
Wang, Y., He, X., Nie, H., Zhou, J., Cao, P., & Ou, C. (2020) · PubMed · Cited by 80
Lin, Y., Zhang, Q., Chen, H., Liu, S., Peng, K., Wang, X., Zhang, L., Huang, J., Yan, X., Lin, X., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-03887-5 · Cited by 63
“Current cancer screening paradigms have been widely used in clinical practice, such as mammography for breast cancer (BC) [3], colonoscopy for colorectal cancer (CC) [4], and low-dose computed tomography (CT) for lung cancer (LC) [5].”
Mehta, S. J., Jensen, C. D., Quinn, V. P., Schottinger, J. E., Zauber, A. G., Meester, R. G. S., Laiyemo, A. O., Fedewa, S. A., Goodman, M. G., Fletcher, R. H., et al. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3792-1 · Cited by 58
Moore, J., & Aulet, T. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.01.001 · Cited by 58
Hamada, T., Soong, T. R., Masugi, Y., Kosumi, K., Nowak, J. A., da Silva, A., Mu, X. J., Twombly, T. S., Koh, H., Yang, J., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1442999 · Cited by 69
“, the Nurses’ Health Study (NHS, 121,701 women aged 30– 55 years followed since 1976) and the Health Professionals Follow-up Study (HPFS, 51,529 men aged 40–75 years followed since 1986).(56) Participants are followed with biennial questionnaires on lifestyle factors and newly-diagnosed diseases including colorectal c…”
BackgroundSelf-citationColorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
Hull, R., Francies, F. Z., Oyomno, M., & Dlamini, Z. (2020) · Cancer Management and Research · doi:10.2147/cmar.s251223 · Cited by 70
Kim, N., Kim, S. M., Seo, J., Park, E.-H., Kim, N., & Lee, D. H. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-82 · Cited by 57
Self-citationBrenner, H., Altenhofen, L., Stock, C., & Hoffmeister, M. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0367 · Cited by 57
“Various screening methods have been proposed and shown to be effective in randomized trials and observational studies, including fecal occult blood testing, sigmoidoscopy and colonoscopy (3-7).”
MethodDesign and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2
Joshi, B. P., Zhou, J. H., Pant, A., Duan, X., Zhou, Q., Kuick, R. D., Owens, S. R., Appelman, H. D., & Wang, T. D. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00565 · Cited by 57
New era of colorectal cancer screening
Zoghbi, M. E., & Cummings, L. C. (2016) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v8.i5.252 · Cited by 69
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
Tinmouth, J., Vella, E. T., Baxter, N. N., Dubé, C., Gould, M., Hey, A., Ismaila, N., McCurdy, B. R., & Paszat, L. F. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/2878149 · Cited by 60
Ugai, T., Väyrynen, J. P., Lau, M. C., Borowsky, J., Akimoto, N., Väyrynen, S. A., Zhao, M. M., Zhong, R., Haruki, K., Costa, A. D., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03056-6 · Cited by 58
Self-citationZessner‐Spitzenberg, J., Waldmann, E. A., Jiricka, L., Rockenbauer, L.-M., Hinterberger, A., Cook, J., Asaturi, A., Szymanska, A., Majcher, B., Trauner, M., et al. (2022) · Endoscopy · doi:10.1055/a-1974-9979 · Cited by 56
Cheung, K. S., Chen, L., Chan, E. W., Seto, W., Wong, I. C. K., & Leung, W. K. (2019) · Gut · doi:10.1136/gutjnl-2018-317714 · Cited by 61
Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers
Tollivoro, T. A., Jensen, C. D., Marks, A. R., Zhao, W. K., Schottinger, J. E., Quinn, V. P., Ghai, N. R., Zauber, A. G., Doubeni, C. A., Levin, T. R., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.023 · Cited by 60
Patient-Reported Attributions for Missed Colonoscopy Appointments in Two Large Healthcare Systems
Bhise, V., Modi, V., Kalavar, A., Espadas, D., Hanser, L., Gould, M., El‐Serag, H. B., & Singh, H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4096-3 · Cited by 58
Park, Y., Ryu, Y., Jung, Y., Wang, T., Baek, Y., Yoon, Y., Bae, S. M., Park, J., Hwang, S., Kim, J., et al. (2014) · ACS Nano · doi:10.1021/nn5009269 · Cited by 55
“Early detection of colorectal cancer with high accuracy is of paramount importance,(2) where colonoscopy is a standard diagnostic tool for colorectal cancer screening and has contributed significantly to reduce mortality.(3) However, colonoscopy sometimes faces difficulties in the rapid and”
Self-citationShirin, H., Shpak, B., Epshtein, J., Karstensen, J. G., Hoffman, A. W., de Ridder, R. J. J., Testoni, P. A., Ishaq, S., Reddy, D. N., Gross, S. A., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.09.028 · Cited by 61
Risk Factors for Serrated Polyps of the Colorectum
Haque, T., Bradshaw, P. T., & Crockett, S. D. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3277-1 · Cited by 54
“Additionally, multiple lines of evidence suggest that serrated pathway precursors contribute to the problem of interval cancers, which is an important concern for gastroenterologists and patients alike [7-12].”
BackgroundNovel Hexosaminidase-Targeting Fluorescence Probe for Visualizing Human Colorectal Cancer
Matsuzaki, H., Kamiya, M., Iwatate, R. J., Asanuma, D., Watanabe, T., & Urano, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00037 · Cited by 53
Okamoto, K., Kitamura, S., Kimura, T., Nakagawa, T., Sogabe, M., Miyamoto, H., Muguruma, N., & Takayama, T. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13482 · Cited by 58
Screening for Colon Cancer in Older Adults: Risks, Benefits, and When to Stop
Nee, J. W., Chippendale, R. Z., & Feuerstein, J. D. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.021 · Cited by 58
NSAIDs and Colorectal Cancer Control: Promise and Challenges
Tsioulias, G. J., Go, M. F., & Rigas, B. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-015-0042-x · Cited by 54
Laique, S. N., Hayat, U., Sarvepalli, S., Vaughn, B. P., Ibrahim, M., McMichael, J. P., Qaiser, K. N., Burke, C. A., Bhatt, A., Rhodes, C., et al. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.08.038 · Cited by 52
“1 4 However, increasing evidence suggests that examination quality may have an impact on its effectiveness, that is, the adenoma detection rate is inversely related to the risk of interval CRC. 5 In 2015, the American Society for Gastrointestinal Endoscopy (ASGE)/American College of…”
BackgroundMima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 53
Self-citationLadabaum, U., Shepard, J. W., & Mannalithara, A. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.04.037 · Cited by 57
Zhang, B., Li, Y., Khan, M. A., Ali, M., Barykin, S., & Jahanzeb, A. (2023) · Sustainability · doi:10.3390/su15031972 · Cited by 58
Lam, A. Y., Li, Y., Gregory, D. L., Prinz, J., O’Reilly, J., Manka, M., Pandolfino, J. E., & Keswani, R. N. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.02.016 · Cited by 56
Polyp detection at colonoscopy: Endoscopist and technical factors
Rex, D. K. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.05.010 · Cited by 50
Wang, Y., Chen, H.-H., Wu, M., & Chiu, H. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.09.010 · Cited by 54
Danese, E., Montagnana, M., & Lippi, G. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.97 · Cited by 51
“, who explored the effectiveness of endoscopy for preventing CRC mortality in over 88,000 participants of the Nurses’ Health Study and the Health Professionals Follow-up Study (7).”
BackgroundZhou, Z., Tan, F., Pei, Q., Li, C., Zhou, Y., Li, Y., & Pei, H. (2021) · Aging · doi:10.18632/aging.202737 · Cited by 49
“Despite the development of CRC therapies in recent years, the prognosis of patients with CRC is still unsatisfactory, with a poor 5-year survival rate [3].”
BackgroundYang, H., Park, S., Kim, J. H., Im, J. P., Yeom, D. H., Seo, G. S., & Park, D. I. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13477 · Cited by 49
Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening
Kotwal, A., & Schonberg, M. A. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000274 · Cited by 53
“There are no published RCTs of colonoscopy, but 1 large prospective cohort showed that adults 75 years or older had a 50% reduction in rates of incident CRC diagnosis in both the proximal and distal colon if at more than 5 years since the last endoscopy and 63% reduction if at less than 5 years from last endoscopy.(44…”
BackgroundPark, Y., Ryu, Y., Wang, T., Jung, Y., Kim, S., Hwang, S., Park, J., Bae, D., Kim, J., Moon, H., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703450 · Cited by 49
Self-citationSmoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells
Hamada, T., Nowak, J. A., Masugi, Y., Drew, D. A., Song, M., Cao, Y., Kosumi, K., Mima, K., Twombly, T. S., Liu, L., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy137 · Cited by 55
Self-citationCarson, T. L., Wang, F., Cui, X., Jackson, B. E., Pol, W. J. V. D., Lefkowitz, E. J., Morrow, C. D., & Baskin, M. L. (2018) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000614 · Cited by 55
“For example, progress has been made in reducing colorectal cancer incidence and mortality as a result of prevention and early detection through screening (6,7); however, colorectal cancer disparities remain, in part, because of access to and utilization of screening along with unknown contributors (7).”
Viramontes, O., Bastani, R., Yang, L., Glenn, B. A., Herrmann, A. K., & May, F. P. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106146 · Cited by 50
Johnson, D. H., Kisiel, J. B., Burger, K. N., Mahoney, D. W., Devens, M. E., Ahlquist, D. A., & Sweetser, S. R. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.11.012 · Cited by 49
Wei, E. K., Colditz, G. A., Giovannucci, E. L., Wu, K., Glynn, R. J., Fuchs, C. S., Stampfer, M. J., Willett, W. C., Ogino, S., & ROSNER, B. A. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww183 · Cited by 55
“Although screening is known to reduce CRC incidence and mortality (40), we observed a substantial role of lifestyle changes in the cumulative incidence of CRC; promoting healthy lifestyles should remain a priority for CRC prevention.”
BackgroundSelf-citationBarriers and Facilitators to Colorectal Cancer Screening Within a Hispanic Population
Byrd, T. L., Calderón-Mora, J., Salaiz, R. A., & Shokar, N. K. (2018) · Hispanic Health Care International · doi:10.1177/1540415318818982 · Cited by 48
“It has been estimated that colonoscopy screening may prevent CRC by 40% to 60% because polyps that might become cancerous can be found and removed at the time of the test (Brenner, Stock, & Hoffmeister, 2014; Coleman et al., 2015; Nishihara et al., 2013).”
BackgroundMehta, S. J., Pepe, R. S., Gabler, N. B., Kanneganti, M., Reitz, C., Saia, C., Teel, J., Asch, D. A., Volpp, K. G., & Doubeni, C. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1156 · Cited by 48
Cheung, K. S., Chan, E. W., Seto, W., Wong, I. C. K., & Leung, W. K. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15317 · Cited by 50
Sessile serrated polyps and colon cancer prevention
Rashtak, S., Rego, R., Sweetser, S. R., & Sinicrope, F. A. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0264 · Cited by 47
Colorectal cancer screening: A review of current knowledge and progress in research
Lopes, S. R., Martins, C., Santos, I. C., Teixeira, M., Gamito, É., & Alves, A. L. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i4.1119 · Cited by 59
“There are no RCT assessing the effectiveness of colonoscopy in reducing CRC incidence and mortality in average-risk patients, but several cohort studies have demonstrated an impact on CRC incidence and mortality for both proximal and distal cancers[38,55-62].”
Proceedings of the second international molecular pathological epidemiology (MPE) meeting
Ogino, S., Campbell, P. T., Nishihara, R., Phipps, A. I., Beck, A. H., Sherman, M. E., Chan, A. T., Troester, M. A., Bass, A. J., Fitzgerald, K. C., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0596-2 · Cited by 49
“For example, colonoscopy may be less effective for reducing risk of MSI-high colorectal cancers than for non-MSI cancers [85, 86], and hence, smokers who are at risk of MSI-high colorectal cancer may need to have different screening strategies.”
Self-citationTumor LINE-1 methylation level and colorectal cancer location in relation to patient survival
Mima, K., Nowak, J. A., Qian, Z. R., Cao, Y., Song, M., Masugi, Y., Shi, Y. X., da Silva, A., Gu, M., Li, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10398 · Cited by 50
“-nationwide prospective cohort studies, the NHS (121,701 women enrolled in 1976) and the HPFS (51,529 men enrolled in 1986) [57, 58].”
BackgroundSelf-citationCarter, J. V., Roberts, H. L., Pan, J., Rice, J. D., Burton, J. F., Galbraith, N. J., Eichenberger, M. R., Jorden, J., Deveaux, P. G., Farmer, R. W., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001873 · Cited by 55
Kudo, T., Saito, Y., Ikematsu, H., Hotta, K., Takeuchi, Y., Shimatani, M., Kawakami, K., Tamai, N., Mori, Y., Maeda, Y., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.06.011 · Cited by 47
A Review of Colonoscopy in Intestinal Diseases
Hong, S. M., & Baek, D. H. (2023) · Diagnostics · doi:10.3390/diagnostics13071262 · Cited by 54
“Individuals who underwent colonoscopy with polypectomy were found to have a 43% reduction in CRC incidence compared to those with no lower endoscopy [106].”
BackgroundResultShergill, A. K., Conners, E. E., McQuaid, K. R., Lewin, S. M., Ryan, J. C., Shah, J. N., Inadomi, J. M., & Somsouk, M. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.01.053 · Cited by 46
Ross, W. A., Thirumurthi, S., Lynch, P. M., Rashid, A., Pande, M., Shafi, M. A., Lee, J. H., & Raju, G. S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.07.030 · Cited by 46
Abdul-Baki, H. A., Schoen, R. E., Dean, K. M., Rose, S., Leffler, D. A., Kuganeswaran, E., Morris, M. M., Carrell, D., & Mehrotra, A. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.12.058 · Cited by 46
Sekiguchi, M., Igarashi, A., Matsuda, T., Matsumoto, M., Sakamoto, T., Nakajima, T., Kakugawa, Y., Yamamoto, S., Saito, H., & Saito, Y. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv186 · Cited by 51
“Recently, however, it has been reported that TCS-based CRC screening, in which TCS is performed as a primary screening procedure, is effective for reducing CRC incidence and mortality, based on long-term follow-up data in cohort studies (15,16).”
BackgroundGawron, A. J., Thompson, W. K., Keswani, R. N., Rasmussen, L. V., & Kho, A. N. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.147 · Cited by 46
Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations
Chan, A. T., & Ladabaum, U. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.018 · Cited by 48
Self-citationJayasekara, H., Reece, J. C., Buchanan, D. D., Rosty, C., Dashti, S. G., Ouakrim, D. A., Winship, I., Macrae, F., Boussioutas, A., Giles, G. G., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30153 · Cited by 45
“25 While evidence is still lacking that the CIMP pathway could independently play a role in accelerated tumour growth, our evidence of a greater risk of metachronous cancer for individuals with an initial cancer in the proximal colon could well be related to CIMP-related interval cancers.”
Yoshida, N., Inoue, K., Tomita, Y., Kobayashi, R., Hashimoto, H., Sugino, S., Hirose, R., Dohi, O., Yasuda, H., Morinaga, Y., et al. (2021) · International Journal of Colorectal Disease · doi:10.1007/s00384-021-04006-5 · Cited by 47
Controversies in Colorectal Cancer Screening
Pox, C. P. (2014) · Digestion · doi:10.1159/000363287 · Cited by 44
Screening for colorectal cancer
Choi, Y., Sateia, H. F., Peairs, K. S., & Stewart, R. W. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.02.002 · Cited by 50
Qian, Z., Zhang, G., Song, G., Shi, J., Gong, L., Mou, Y., & Han, Y. K. (2017) · Oncotarget · doi:10.18632/oncotarget.16064 · Cited by 44
Self-citation
Metadata
- Authors
- Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., Imamura, Y., Willett, W. C., Rosner, B. A., Fuchs, C. S., Giovannucci, E., Ogino, S., & Chan, A. T.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-09-19
- Volume
- 369
- Issue
- 12
- Pages
- 1095-1105
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3840160
- OpenAlex
- W2143929290
- Semantic Scholar
- 778a578187bee44d1da1af275742817bc03017d3
- Cited by
- 1,483
- References
- 44
- Citations by year
- 2026: 42 · 2025: 77 · 2024: 105 · 2023: 102 · 2022: 108 · 2021: 144 · 2020: 139 · 2019: 118 · 2018: 121 · 2017: 124 · 2016: 140 · 2015: 141 · 2014: 102 · 2013: 12
- FWCI
- 70.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, R01CA151993, R01CA137178, P01CA087969, P01CA055075, UM1CA167552)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311, P30DK043351)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- colorectal cancer, colonoscopy, sigmoidoscopy, colorectal cancer screening, right-sided colon cancer, cancer incidence, cancer mortality, polypectomy, CpG island methylator phenotype, microsatellite instability, Lynch syndrome, Nurses' Health Study, Health Professionals Follow-up Study, timing of endoscopy, DNA methylation, tumor suppressor
- MeSH terms
- Adenoma, Aged, Colonic Polyps, Colonoscopy, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sigmoidoscopy, United States, Colorectal Neoplasms, Cohort Studies, Incidence, Multivariate Analysis, Microsatellite Instability, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.